Incyte Corp (INCY)
51.72
+0.54
(+1.06%)
USD |
NASDAQ |
Apr 26, 16:00
51.72
0.00 (0.00%)
After-Hours: 18:02
Incyte Profit Margin (Quarterly): 19.84% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 19.84% |
September 30, 2023 | 18.64% |
June 30, 2023 | 21.32% |
March 31, 2023 | 2.68% |
December 31, 2022 | 3.07% |
September 30, 2022 | 13.70% |
June 30, 2022 | 17.71% |
March 31, 2022 | 5.18% |
December 31, 2021 | 65.35% |
September 30, 2021 | 22.35% |
June 30, 2021 | 21.18% |
March 31, 2021 | 8.85% |
December 31, 2020 | 18.98% |
September 30, 2020 | -2.45% |
June 30, 2020 | 42.19% |
March 31, 2020 | -126.8% |
December 31, 2019 | 19.16% |
September 30, 2019 | 23.26% |
June 30, 2019 | 19.87% |
March 31, 2019 | 20.55% |
December 31, 2018 | 13.07% |
September 30, 2018 | 6.49% |
June 30, 2018 | 10.05% |
March 31, 2018 | -10.76% |
December 31, 2017 | -33.69% |
Date | Value |
---|---|
September 30, 2017 | 9.45% |
June 30, 2017 | -3.82% |
March 31, 2017 | -48.71% |
December 31, 2016 | 2.72% |
September 30, 2016 | 13.69% |
June 30, 2016 | 13.98% |
March 31, 2016 | 9.13% |
December 31, 2015 | 22.62% |
September 30, 2015 | -21.10% |
June 30, 2015 | 5.70% |
March 31, 2015 | -11.53% |
December 31, 2014 | -29.80% |
September 30, 2014 | 29.92% |
June 30, 2014 | -37.03% |
March 31, 2014 | -37.82% |
December 31, 2013 | -44.16% |
September 30, 2013 | -25.89% |
June 30, 2013 | -2.53% |
March 31, 2013 | -22.05% |
December 31, 2012 | 16.50% |
September 30, 2012 | -35.89% |
June 30, 2012 | 4.66% |
March 31, 2012 | -125.6% |
December 31, 2011 | -190.7% |
September 30, 2011 | -316.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-126.8%
Minimum
Mar 2020
65.35%
Maximum
Dec 2021
11.27%
Average
18.98%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
Novartis AG | 22.18% |
MorphoSys AG | 81.70% |
Illumina Inc | -15.60% |
Biogen Inc | 17.18% |
Pfizer Inc | -23.64% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 12.61% |
Return on Assets | 9.63% |
Return on Invested Capital | 12.61% |
Gross Profit Margin (Quarterly) | 93.11% |
Operating Margin (Quarterly) | 19.96% |
Return on Net Operating Assets | 33.86% |